Cross-talk between phosphatidic acid and ceramide during ethanol-induced apoptosis in astrocytes
© Schatter et al; licensee BioMed Central Ltd. 2005
Received: 12 August 2004
Accepted: 04 February 2005
Published: 04 February 2005
Ethanol inhibits proliferation in astrocytes, an effect that was recently linked to the suppression of phosphatidic acid (PA) formation by phospholipase D (PLD). The present study investigates ethanol's effect on the induction of apoptosis in astrocytes and the formation of ceramide, an apoptotic signal. Evidence is presented that the formation of PA and ceramide may be reciprocally linked during ethanol exposure.
In cultured rat cortical astrocytes, ethanol (0.3–1 %, v/v) induced nuclear fragmentation and DNA laddering indicative of apoptosis. Concomitantly, in cells prelabeled with [3H]-serine, ethanol caused a dose-dependent, biphasic increase of the [3H]-ceramide/ [3H]-sphingomyelin ratio after 1 and 18 hours of incubation. As primary alcohols such as ethanol and 1-butanol were shown to inhibit the phospholipase D (PLD)-mediated formation of PA, a mitogenic lipid messenger, we tested their effects on ceramide formation. In astrocytes prelabeled with [3H]-serine, ethanol and 1-butanol, in contrast to t-butanol, significantly increased the formation of [3H]-ceramide. Moreover, exogenous PA, added to transiently permeabilized astrocytes, suppressed ethanol-induced [3H]-ceramide formation. Vice versa, addition of C2-ceramide to astrocytes inhibited PLD activity induced by serum or phorbol ester.
We propose that the formation of ceramide in ethanol-exposed astrocytes is secondary to the disruption of phospholipase D signaling. Ethanol reduces the PA:ceramide ratio in fetal astrocytes, a mechanism which likely participates in ethanol-induced glial apoptosis during brain development.
The proliferation of astrocytes is stimulated by polypeptide growth factors such as PDGF, EGF, bFGF and IGF-1 acting on cellular signaling pathways which involve tyrosine kinases, protein kinase C, and the Ras-Raf-MAP kinase pathway [1, 2]. Astroglial proliferation is also stimulated by neurotransmitters such as acetylcholine and glutamate [3, 4], by direct stimulation of protein kinase C with phorbol ester [5, 6], and by peptides such as endothelin and prolactin [7, 8]. Astroglial proliferation is prominently inhibited by ethanol both in vivo and in vitro [9–11], and this interference likely contributes to the development of the fetal alcohol syndrome (alcoholic embryopathy) (reviewed in ). Ethanol has been shown to potently antagonize proliferative effects of several individual astroglial mitogens including PDGF, IGF-1, acetylcholine and prolactin [8, 13–15].
The molecular target of ethanol's antimitogenic actions in astroyctes is not known with certainty, but inhibitory interactions of ethanol with lipid signaling pathways have been implicated . Our group has recently reported strong evidence that the growth-inhibitory effect of ethanol in astrocytes is caused by the disruption of the phospholipase D (PLD) signaling pathway [16, 17]. Under physiological conditions, PLD catalyzes the hydrolysis of phosphatidylcholine (PC) to yield phosphatidic acid (PA) and choline. In the presence of ethanol, however, PLD forms phosphatidylethanol (PEth), a non-physiological phospholipid, at the expense of PA. This PLD-specific phenomenon of transphosphatidylation is the reason why downstream events mediated by PLD activation and PA formation are dose-dependently inhibited in the presence of ethanol (or other primary alcohols such as 1-butanol).
In our previous work, we have found that astroglial PLD is activated by mitogenic factors including fetal calf serum (FCS), PDGF, and phorbol ester, and we observed that ethanol reduced both astroglial proliferation and PA formation in a parallel manner. 1-butanol reduced PA formation and DNA synthesis with the same potency while t-butanol was inactive for both effects . More recently, we demonstrated that exogenous PLD as well as PA, when introduced into the cytosol by transient permeabilization, stimulated astroglial cell proliferation. Importantly, the action of PLD was suppressed in the presence of ethanol (0.3 %, v/v) while the mitogenic effect of PA was not affected . Thus, disruption of the PLD signaling pathway by ethanol is sufficient to suppress astroglial cell proliferation.
Recent findings from other groups are also compatible with a central role for the PLD signaling pathway in ethanol toxicity in astrocytes. First, several mitogenic factors including those that are known to be particularly sensitive to ethanol activate PLD activity in astrocytes. This holds true for PDGF , acetylcholine [5, 18], glutamate , phorbol esters [5, 6], endothelin [20, 21], and prolactin . In fact, disruption of PLD signaling by ethanol was recently found to be responsible for ethanol's inhibitory effect on astroglial DNA synthesis induced by muscarinic agonist . Second, PLD is activated via the mitogenic Ras-Ral pathway in many cell types , and PA, the immediate product of PLD activity, interacts with and activates proteins such as Raf kinase, protein kinase Cζ, and mTOR which are known to be central to mitogenic signaling (reviewed in [25, 26]). In addition, PA is a precursor of diacylglycerol (DAG), the endogenous activator of classical PKC's, and of lyso-PA, a potent mitogen in many cell types [25, 26]. Taken together, current evidence suggests that intact PLD signaling is a prerequisite for the proliferative effects of several mitogens, and that disruption of the PLD pathway by ethanol may be a common theme in ethanol-induced inhibition of astroglial proliferation.
The present study in fetal astrocytes was motivated by recent reports that ethanol induces apoptosis in astrocytes, an effect that was accompanied by activation of the sphingomyelinase pathway and formation of ceramide [27, 28]. Apoptosis denotes an active cellular program causing cellular death upon contact with toxicants. Apoptotic cell death in the CNS has been under intensive study in recent years and involves several intracellular reaction cascades linked by the activation of caspases (reviewed in ). Apoptosis is almost universally accompanied by the formation of ceramide which may occur through de novo-synthesis, inhibition of ceramide breakdown, or activation of (acidic and/or neutral) sphingomyelinase (SMase), an enzyme which catalyzes the hydrolysis of sphingomyelin to ceramide and phosphocholine (see  for review). Ceramide has emerged as a second messenger for apoptotic pathways targeting kinases and phosphatases which are required for the execution of apoptotic cell death (reviewed in [31, 32]). In cerebellar astrocytes and in glioma cells, ceramide levels were found to be reciprocally related to cell proliferation [33, 34]. For the present study, we developed the hypothesis that the formation of ceramide may be secondary to the inhibition of PLD signaling which we had described earlier (see above). We now report that ethanol-induced ceramide formation in astrocytes is mimicked by 1-butanol, but not by t-butanol, and that PA, the product of PLD activity, antagonizes ethanol-induced formation of ceramide. We also found that ceramide is a potent inhibitor of stimulated PLD activity. Thus, we obtained evidence of a cross-talk between PA and ceramide, two lipid messengers with opposite effects on cellular proliferation.
Markers of apoptosis
Effects of ethanol on sphingomyelin hydrolysis
The rapid and transient phase of ceramide formation occurred within 15 min and reached a maximum at 1 hour after addition of ethanol (1 h value without ethanol: 2.93 ± 0.35%; 1 h value with 0.3% ethanol: 3.92 ± 0.60%; p = 0.02). A second increase gradually developed after 4 hours and reached a maximum at 18 hours of ethanol exposure (18 h value without ethanol: 3.46 ± 0.41 %; 18 h value with ethanol: 4.18 ± 0.51 %; p = 0.005). At this later time point, staurosporine (1 μM) caused an increase of the C/S ratio to 7.97 ± 1.78 % (p < 0.01; not illustrated).
Inhibition of ceramide formation by PLD activity and phosphatidic acid
Inhibition of phospholipase D activity by ceramide
We have previously documented that ethanol suppresses signaling through the mitogenic phospholipase D (PLD) pathway, and we and others have provided evidence that this effect may be responsible for the antiproliferative actions of ethanol in astrocytes [16, 17, 23]. The present study was motivated by findings that ethanol induces astroglial apoptosis via activation of the sphingomyelinase pathway [27, 28]. We confirm these earlier reports by showing the induction of apoptotic markers and ceramide formation in ethanol-treated astrocytes. The novel finding of our study is that ethanol-induced formation of ceramide is reciprocally regulated by phosphatidic acid (PA) and the phospholipase D pathway which is itself inhibited by ceramide.
We used three different approaches to demonstrate that apoptotic cell death in astrocytes can be induced by exposure to ethanol. First, we report that ethanol can induce nuclear condensation and degradation (Fig. 1). Second, application of ethanol to serum-starved astroglial cultures caused "DNA laddering", a typical hallmark of apoptotic degradation of nuclear DNA (Fig. 2). The effect of ethanol was mimicked by a cell-permeable ceramide, C2-ceramide (Fig. 2), and by staurosporine (not illustrated). Third, ethanol induced an increase of ceramide in astroglial cultures (Figs. 3 and 4). Our findings clearly confirm that ethanol can induce apoptosis and ceramide formation in astrocytes, a finding which is in agreement with some  but not all  previous studies.
We performed a time course of [3H]-ceramide formation after ethanol exposure and found that it was maximal at 1 and 18 hours. Biphasic formations of ceramide such as those observed here have been described previously in a range of peripheral cell types although their significance is unclear; they may reflect different modes of ceramide formation, or different pools of ceramide . At both time points of maximum ceramide formation (1 hour and 18 hours), we observed the same ethanol-evoked enhancement of ceramide formation. Importantly, apoptotic cell death and ceramide formation were induced by ethanol levels as low as 65 mM which corresponds to blood alcohol levels (0.3%) which are found in heavy drinkers.
It should be noted that the present experiments do not unequivocally identify the mechanism of ceramide formation. We used [3H]-serine to pre-label sphingomyelin for 72 hours, removed the precursor, and measured formation of ceramide as an increase of the [3H]-ceramide/ [3H]-sphingomyelin ratio during incubations with ethanol. This ratio most likely reflects the activity of sphingomyelinase(s), and sphingomyelinase activity was actually shown to be responsible for ethanol-induced ceramide formation in a recent study . However, our present data do not exclude alternative pathways of increased ceramide formation such as de novo-synthesis of ceramide or inhibition of ceramidase.
The important findings of this study relate to the interaction between lipid second messenger pathways. It was known from previous work (see Introduction) that PA, the product of phospholipase D (PLD), mediates mitogenic stimulation in astrocytes whereas formation of ceramide by sphingomyelinase activation accompanies apoptosis. We now tested the hypothesis that ethanol causes astroglial apoptosis by inhibiting PLD and, as a consequence, stimulates the sphingomyelinase pathway. The results shown in Figs. 5 and 6 are evidence of a direct inhibitory influence of the PLD pathway on ceramide formation. First, we observed that the addition of 1-butanol, a primary alcohol which suppresses PLD signaling, caused an increase of ceramide levels (Fig. 5). This effect was not seen with the inactive isomer t-butanol which does not interfere with PLD signaling in astrocytes (see our previous study ). Second, we used transient permeabilization of astrocytes by streptolysin-O to introduce PA, the product of PLD, into the astroglial cytosol [17, 37]. We found that exogenous PA almost completely prevented the ethanol-induced increase of ceramide at early (1 hr) and delayed (18 hrs) phases of ceramide formation (Fig. 6). The fact that ethanol and 1-butanol, but not t-butanol increase ceramide formation, whereas PA antagonized this effect, gives strong evidence that PLD-mediated formation of PA keeps ceramide levels low under basal conditions (Fig. 5), and that PLD activity antagonizes ceramide formation under the influence of toxicants (Fig. 6). Unfortunately, we could not determine the effect of exogenous PA on astroglial apoptosis because the permeabilization procedure was found to induce a delayed apopototic response in astrocytes (not shown).
We also probed the reciprocal effects of ceramide signaling on PLD activity. The results shown in Fig. 7 demonstrate that C2-ceramide inhibits PLD activity at a concentration as low as 10 μM. Basal PLD activity was only slightly inhibited, but the increases of PLD activity induced by addition of serum or phorbol ester were strongly antagonized. This finding in astrocytes corroborates previous reports that ceramide can inhibit PLD signaling in peripheral cell types [38, 39]. It remains a matter of speculation why serum-induced PLD was somewhat more susceptible to inhibition by ceramide than phorbol ester-stimulated activity. Growth factors in serum and phorbol ester may affect different signaling pathways leading to PLD activation, and we previously presented inhibition data with bacterial toxins which supported this idea for astroglial PLD . Interestingly, ethanol was also observed to inhibit serum- and growth factor-mediated astroglial proliferation more effectively than phorbol ester-induced proliferation [6, 16]. At this time, we cannot distinguish which isoform of PLD is responsible for PA formation; previous attempts to selectively down-regulate astroglial PLDs failed due to the long biological half-lives of the proteins . The molecular target of ceramide for inhibiting PLD also remains to be identified; previous work has implicated direct inhibition of PLD by ceramide as well as upstream molecules such as protein kinase C which activate PLD [42, 43].
[3H]-Serine and [3H]-glycerol were from Biotrend (Köln, Germany). Ceramide (from bovine brain), C2-ceramide (N-acetyl-D-erythro-sphingosine), and staurosporine were from Alexis (Lausen, Switzerland). Hoechst 33258, L-α-phosphatidic acid (sodium salt, from egg yolk) and 4β-phorbol-12β,13α-dibutyrate (PDB) were from Sigma (Deisenhofen, Germany); most other chemicals and TLC plates were obtained from Merck (Darmstadt, Germany) or Roth (Karlsruhe, Germany) at the highest purity available. Fetal calf serum (South America) was from Invitrogen, cell culture materials were from Sarstedt (Nürnbrecht, Germany). Phosphatidylethanol (PEth) standard was synthesized as described . Recombinant, oxygen-insensitive streptolysin-O (C530A) was prepared as described .
Astrocyte-rich cultures were prepared from newborn rat pups. Cerebral hemispheres were collected, meninges and blood vessels were removed, the brain tissue was dissociated by trituration, passed through a 50 μm nylon mesh, and the cells were seeded onto plastic culture dishes (14,000 cells per cm2). The growth medium was DMEM containing 10% fetal calf serum (FCS), 2 g/l NaHCO3, 100 U/ml penicillin and 100 μg/ml streptomycin. The cells were incubated at 37°C in a 95/5% mixture of air and carbon dioxide. For the experiments, astrocytes were grown for two weeks in culture and were used when they reached confluency. As judged by GFAP immunostaining, these cultures contained >90% astrocytes.
Cells were seeded on microplates (5,000 cells per 200 μl) and incubated with different apoptogens (ethanol 0.3 and 1 %, C2-ceramide 50 μM or staurosporine 1 μM) for 24 hrs in serum-free medium. Subsequently, cells were washed and fixed with ice-cold methanol/acetic acid (3:1). Dried and re-hydrated cells were stained with bisbenzimide (Hoechst 33258, 1 μg/ml) solution for 10 min, washed and sealed in gelatin. Photographs were obatined using a Leica Leitz DMRB fluorescence microscope and a Nikon Digital Camera DXM.
The test was carried out as described  with some modifications. Briefly, cells were incubated with apoptogens (Ethanol 0,3%, 1%; C2-Ceramide 50 μM) in serum-free medium. Then, the cells were transferred and resuspended in Tris-EDTA buffer containing 0.5% Igepal CA 630. Further lysis was performed in buffer containing RNAse A (100 μg/μl), proteinase K (0,5 μg/ml) and SDS (1.2 %). After 5 minutes, the clear solution was mixed with 3 M CsCl in acetate buffer. Precipitated debris and chromosomal DNA was removed by centrifugation, and the supernatant was loaded onto a QIAprep column (twice), centrifuged and eluted by hypotonic Tris-EDTA buffer. The eluate was analyzed by electrophoresis on a 3 % agarose gel and visualized with ethidium bromide.
Measurement of [3H]-ceramide formation
Phospholipids were labeled by addition of [3H]-serine (1 μCi/ml) to astrocytes kept in growth medium (DMEM plus FCS) for 72 h. After washing, cells were incubated in serum-free medium with ethanol, butanol, C2-ceramide or staurosporine (see Results). C2-ceramide or staurosporine were added in DMSO; the final DMSO concentration was < 0.1 %. At the end of the incubation, cells were fixed with methanol, transferred and extracted first with with chloroform: methanol (1:1), then with chloroform: methanol: water (10:10:9) to separate water and lipid phases. After addition of ceramide and sphingomyelin standards, the lower (lipid) phase was evaporated, taken up in chloroform:methanol (3:2) and separated by thin-layer chromatography (TLC). For the determination of [3H]-ceramide, we used one-dimensional TLC (HP-TLC plates Merck 11845; eluent: chloroform/acetic acid 9:1). For the determination of [3H]-sphingomyelin, we used two-dimensional TLC (TLC plates Merck 1.05721); solvent I was chloroform/methanol/25% aqueous ammonia (13:7:1), solvent II was chloroform/ methanol/water/acetic acid (30:30:2:5). 3H-lipids were visualized by using iodine vapor, spots were scraped and suspended in scintillation cocktail (Lumasafe Plus), and radioactivity was measured by liquid scintillation counting (Packard 1600 CA). Formation of [3H]-ceramide was calculated as percentage of radioactivity found in [3H]-sphingomyelin.
For the introduction of PA, astrocytes were transiently permeabilized with streptolysin-O . Briefly, astrocytes were washed and exposed to an oxygen-insensitive mutant of streptolysin-O (C530A) in calcium-free HBSS buffer (prepared by dissolving 8 g NaCl, 0.4 g KCl, 60 mg KH2PO4, 60 mg Na2HPO4 × 2 H2O, 100 mg glucose in 1 L of sterile water). PA (sodium salt; 200 μM) was added as a suspension in buffer prepared by sonication. After 15 min, the cells were washed and incubated in serum-free, calcium-containing DMEM. Formation of [3H]-ceramide was determined as described above. Ethanol, if present, was present throughout the incubation period. Using 144 ng/ml of streptolysin-O, this procedure yielded transient permeabilization of > 80% of astrocytes followed by repair of the pore in > 80% of permeabilized cells. The procedure was previously found to allow the entry of approx. 106 molecules of PA per cell .
Determination of phospholipase D activity
Phospholipase D activity was determined using the transphosphatidylation assay . For this purpose, astrocytes were kept in serum-free medium containing [3H]-glycerol (1 μCi/ml) for 24 h in order to label phospholipids. More than 60% of the phospholipid label was associated with phosphatidylcholine (not illustrated). Subsequently, the cells were washed and re-exposed to medium containing ethanol (2 %) and PDB (1.0 μM) or FCS (10 %, v/v) as stimulators. PDB and C2-ceramide, when used, were dissolved in DMSO (end concentration of DMSO < 0.1 %). After 30 min of reaction time, the cells were washed in cold phosphate-buffered saline and extracted as described above for ceramide determinations. After addition of phosphatidylethanol (PEth) and PA standards, aliquots of the lipid phase were separated by two-dimensional TLC (TLC plate Merck 1.05721) using chloroform/methanol/25 % aqueous ammonia (13:7:1) for the first run and the upper phase of ethylacetate/isooctane/ acetic acid/water (13:2:3:10) for the second run. Individual phospholipids were stained by iodine, and the spots corresponding to PEth, PA and phosphatidylcholine (PC) were isolated and counted for radioactivity in a scintillation counter. To determine PLD activity, formation of [3H]- PEth was calculated as percentage of [3H]-PC.
Data are shown as means ± SEM of N experiments whereby N refers to the number of different astroglial preparations from different animals. Results were obtained from two replicate dishes which were pooled to represent a single experiment. Statistical calculations were performed by GraphPad InStat 3.0 program package, using analysis of variance (ANOVA) of paired or unpaired data as indicated in text and figure legends.
fetal alcohol syndrome
fetal calf serum
protein kinase C
The authors are grateful to Dr. Ivan Walev, Department of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz, for supplying oxygen-insensitive streptolysin-O, and to the Deutsche Forschungsgemeinschaft for financial support (Kl 598/5–3).
- Labourdette G, Sensenbrenner M: Growth factors and their receptors in the central nervous system. Neuroglia. Edited by: Kettenmann H and Ransom BR. 1995, Oxford: University Press, 441-459.Google Scholar
- Bhat NR: Signal transduction mechanisms in glial cells. Dev Neurosci. 1995, 17: 267-284.View ArticlePubMedGoogle Scholar
- Guizzetti M, Costa LG: Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol. J Neurochem. 1996, 67: 2236-2245.View ArticlePubMedGoogle Scholar
- Schinkmann KA, Kim TA, Avraham S: Glutamate-stimulated activation of DNA synthesis via mitogen-activated protein kinase in primary astrocytes: involvement of protein kinase C and related adhesion focal tyrosine kinase. J Neurochem. 2000, 74: 1931-1940. 10.1046/j.1471-4159.2000.0741931.x.View ArticlePubMedGoogle Scholar
- Mangoura D, Sogos V, Pelletiere C, Dawson G: Differential regulation of phospholipases C and D by phorbol esters and the physiological activators carbachol and glutamate in astrocytes from chicken embryo cerebrum and cerebellum. Brain Res Dev Brain Res. 1995, 87: 12-21. 10.1016/0165-3806(95)00047-H.View ArticlePubMedGoogle Scholar
- Kötter K, Jin S, Klein J: Inhibition of astroglial cell proliferation by alcohols: interference with the protein kinase C-phospholipase D signaling pathway. Int J Dev Neurosci. 2000, 18: 825-831. 10.1016/S0736-5748(00)00044-7.View ArticlePubMedGoogle Scholar
- Lazarini F, Strosberg AD, Courand PO, Cazaubon SM: Coupling of ETB endothelin receptor to mitogen-activated protein kinase stimulation and DNA synthesis in primary cultures of rat astrocytes. J Neurochem. 1996, 66: 459-465.View ArticlePubMedGoogle Scholar
- DeVito WJ, Stone S, Mori K: Low concentrations of ethanol inhibits prolactin-induced mitogenesis and cytokine expression in cultured astrocytes. Endocrinology. 1997, 138: 922-928. 10.1210/en.138.3.922.View ArticlePubMedGoogle Scholar
- Kennedy LA, Mukerji S: Ethanol neurotoxicity. 1. Direct effects on replicating astrocytes. Neurobehav Toxicol Teratol. 1986, 8: 11-15.PubMedGoogle Scholar
- Snyder AK, Singh SP, Ehmann S: Effects of ethanol on DNA, RNA, and protein synthesis in rat astrocyte cultures. Alcohol Clin Exp Res. 1992, 16: 295-300.View ArticlePubMedGoogle Scholar
- Miller MW, Robertson S: Prenatal exposure to ethanol alters the postnatal development and transformation of radial glia to astrocytes in the cortex. J Comp Neurol. 1993, 337: 253-266. 10.1002/cne.903370206.View ArticlePubMedGoogle Scholar
- Guerri C, Pascual M, Renau-Piqueras J: Glia and fetal alcohol syndrome. Neurotoxicology. 2001, 22: 593-599. 10.1016/S0161-813X(01)00037-7.View ArticlePubMedGoogle Scholar
- Luo J, Miller MW: Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: site of ethanol action. J Neurosci. 1999, 19: 10014-10025.PubMedGoogle Scholar
- Resnicoff M, Rubini M, Baserga R, Rubin R: Ethanol inhibits insulin-like growth factor-1 mediated signalling and proliferation of C6 rat glioblastoma cells. Lab Invest. 1994, 71: 657-662.PubMedGoogle Scholar
- Costa LG, Guizzetti M: Inhibition of muscarinic receptor-induced proliferation of astroglial cells by ethanol: mechanisms and implications for the fetal alcohol syndrome. Neurotoxicology. 2002, 23: 685-691. 10.1016/S0161-813X(02)00009-8.View ArticlePubMedGoogle Scholar
- Kötter K, Klein J: Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling. J Neurochem. 1999, 73: 2517-23. 10.1046/j.1471-4159.1999.0732517.x.View ArticlePubMedGoogle Scholar
- Schatter B, Walev I, Klein J: Mitogenic effects of phospholipase D and phosphatidic acid in transiently permeabilized astrocytes: effects of ethanol. J Neurochem. 2003, 87: 95-100. 10.1046/j.1471-4159.2003.01971.x.View ArticlePubMedGoogle Scholar
- Gustavsson L, Lundqvist C, Hansson E: Receptor-mediated phospholipase D activity in primary astroglial cultures. Glia. 1993, 8: 249-255. 10.1002/glia.440080405.View ArticlePubMedGoogle Scholar
- Servitja JM, Masgrau R, Sarri E, Picatoste F: Group I metabotropic glutamate receptors mediate phospholipase D stimulation in rat cultured astrocytes. J Neurochem. 1999, 72: 1441-1447. 10.1046/j.1471-4159.1999.721441.x.View ArticlePubMedGoogle Scholar
- Desagher S, Cordier J, Glowinski J, Tence M: Endothelin stimulates phospholipase D in striatal astrocytes. J Neurochem. 1997, 68: 78-87.View ArticlePubMedGoogle Scholar
- Servitja JM, Masgrau R, Sarri E, Picatoste F: Involvement of ET(A) and ET(B) receptors in the activation of phospholipase D by endothelins in cultured rat cortical astrocytes. Br J Pharmacol. 1998, 124: 1728-1734. 10.1038/sj.bjp.0701997.PubMed CentralView ArticlePubMedGoogle Scholar
- Mangoura D, Pelletiere C, Leung S, Sakellaridis N, Wang DX: Prolactin concurrently activates src-PLD and JAK/Stat signaling pathways to induce proliferation while promoting differentiation in embryonic astrocytes. Int J Dev Neurosci. 2000, 18: 693-704. 10.1016/S0736-5748(00)00031-9.View ArticlePubMedGoogle Scholar
- Guizzetti M, Thompson BD, Kim Y, VanDeMark K, Costa LG: Role of phospholipase D signaling in ethanol-induced inhibition of carbachol-stimulated DNA synthesis of 1321N astrocytoma cells. J Neurochem. 2004, 90: 646-653. 10.1111/j.1471-4159.2004.02541.x.View ArticlePubMedGoogle Scholar
- Foster DA, Xu L: Phospholipase D in cell proliferation and cancer. Mol Cancer Res. 2003, 1: 789-900.PubMedGoogle Scholar
- Exton JH: Phospholipase D – structure, regulation and function. Rev Physiol Biochem Pharmacol. 2002, 144: 1-94.View ArticlePubMedGoogle Scholar
- McDermott M, Wakelam MJ, Morris AJ: Phospholipase D. Biochem Cell Biol. 2004, 82: 225-253. 10.1139/o03-079.View ArticlePubMedGoogle Scholar
- Mangoura D, Dawson G: Programmed cell death in cortical chick embryo astrocytes is associated with activation of protein kinase PK60 and ceramide formation. J Neurochem. 1998, 70: 130-138.View ArticlePubMedGoogle Scholar
- Pascual M, Valles SL, Renau-Piqueras J, Guerri C: Ceramide pathways modulate ethanol-induced cell death in astrocytes. J Neurochem. 2003, 87: 1535-1545.View ArticlePubMedGoogle Scholar
- Sastry PS, Rao KS: Apoptosis and the central nervous system. J Neurochem. 2000, 74: 1-20. 10.1046/j.1471-4159.2000.0740001.x.View ArticlePubMedGoogle Scholar
- Andrieu-Abade N, Levade T: Sphingomyelin hydrolysis during apoptosis. Biochem Biophys Acta. 2002, 1585: 126-134.Google Scholar
- Mathias S, Pena LA, Kolesnick RN: Signal transduction of stress via ceramide. Biochem J. 1998, 335: 465-480.PubMed CentralView ArticlePubMedGoogle Scholar
- Pettus BJ, Chalfant CE, Hannun YA: Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta. 2002, 1585: 114-125.View ArticlePubMedGoogle Scholar
- Riboni L, Viani P, Bassi R, Szabilini A, Tettamanti G: Biomodulatory role of ceramide in basic fibroblast growth factor-induced proliferation of cerebellar astrocytes in primary culture. Glia. 2000, 32: 137-145. 10.1002/1098-1136(200011)32:2<137::AID-GLIA30>3.0.CO;2-2.View ArticlePubMedGoogle Scholar
- Riboni L, Tettamanti G, Viani P: Ceramide in primary astrocytes from cerebellum: metabolism and role in cell proliferation. Cerebellum. 2002, 1: 129-135. 10.1080/147342202753671268.View ArticlePubMedGoogle Scholar
- Holownia A, Ledig M, Menez JF: Ethanol-induced cell death in cultured rat astroglia. Neurotoxicol Teratol. 1997, 19: 141-146. 10.1016/S0892-0362(96)00226-7.View ArticlePubMedGoogle Scholar
- Hannun Y: Functions of ceramide in coordinating cellular responses to stress. Science. 1996, 274: 1855-1859. 10.1126/science.274.5294.1855.View ArticlePubMedGoogle Scholar
- Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva A, Aktories K, Bhakdi S: Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci USA. 2001, 98: 3185-3190. 10.1073/pnas.051429498.PubMed CentralView ArticlePubMedGoogle Scholar
- Gomez-Munoz A, Waggoner DW, O'Brien L, Brindley DN: Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem. 1995, 270: 26318-26325. 10.1074/jbc.270.44.26318.View ArticlePubMedGoogle Scholar
- Nakamura Y, Nakashima S, Ojio K, Banno Y, Miyata H, Nozawa Y: Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells. J Immunol. 1996, 156: 256-262.PubMedGoogle Scholar
- Kötter K, Jin S, von Eichel-Streiber C, Park JB, Ryu SH, Klein J: Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. Biochim Biophys Acta. 2000, 1485: 153-162.View ArticlePubMedGoogle Scholar
- Jin S, Schatter B, Weichel O, Walev I, Ryu SH, Klein J: Stability of phospholipase D in primary astrocytes. Biochem Biophys Res Commun. 2002, 297: 545-551. 10.1016/S0006-291X(02)02231-3.View ArticlePubMedGoogle Scholar
- Jones MJ, Murray AW: Evidence that ceramide selectively inhibits protein kinase C-α translocation and modulates bradykinin activation of phospholipase D. J Biol Chem. 1995, 270: 5007-5013. 10.1074/jbc.270.10.5007.View ArticlePubMedGoogle Scholar
- Singh IN, Stromberg LM, Bourgoin SG, Sciorra VA, Morris AJ, Brindley DN: Ceramide inhibition of mammalian phospholipase D1 and D2 activities is antagonized by phosphatidylinositol-4,5-bisphosphate. Biochemistry. 2001, 40: 11227-11233. 10.1021/bi010787l.View ArticlePubMedGoogle Scholar
- Weller U, Müller L, Messner M, Palmer M, Valeva A, Tranum-Jensen J, Agrawal P, Biermann C, Dobereiner A, Kehoe MA, Bhakdi S: Expression of active streptolysin O in Escherichia coli as a maltose-binding-protein-streptolysin-O fusion protein. Eur J Biochem. 1996, 236: 34-39. 10.1111/j.1432-1033.1996.00034.x.View ArticlePubMedGoogle Scholar
- Arad U: Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells. BioTechniques. 1998, 24: 760-762.PubMedGoogle Scholar
- Morris AJ, Frohman MA, Engebrecht J: Measurement of phospholipase D activity. Anal Biochem. 1997, 252: 1-9. 10.1006/abio.1997.2299.View ArticlePubMedGoogle Scholar